Greenwich Wealth Management’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $953K | Sell |
7,921
-137
| -2% | -$15.8K | 0.04% | 156 |
|
|
2025
Q4 | $848K | Sell |
8,058
-279
| -3% | -$26.2K | 0.04% | 162 |
|
|
2025
Q3 | $700K | Buy |
8,337
+717
| +9% | +$59.1K | 0.03% | 178 |
|
|
2025
Q2 | $603K | Buy |
7,620
+1,205
| +19% | +$95.8K | 0.03% | 164 |
|
|
2025
Q1 | $576K | Sell |
6,415
-257
| -4% | -$24K | 0.04% | 153 |
|
|
2024
Q4 | $664K | Buy |
6,672
+1,686
| +34% | +$174K | 0.05% | 143 |
|
|
2024
Q3 | $566K | Sell |
4,986
-317
| -6% | -$37.7K | 0.04% | 160 |
|
|
2024
Q2 | $657K | Buy |
5,303
+45
| +0.9% | +$5.8K | 0.05% | 137 |
|
|
2024
Q1 | $694K | Sell |
5,258
-233
| -4% | -$28.7K | 0.06% | 139 |
|
|
2023
Q4 | $599K | Sell |
5,491
-499
| -8% | -$51.8K | 0.06% | 147 |
|
|
2023
Q3 | $617K | Sell |
5,990
-1,478
| -20% | -$159K | 0.07% | 140 |
|
|
2023
Q2 | $862K | Sell |
7,468
-140
| -2% | -$15.9K | 0.09% | 115 |
|
|
2023
Q1 | $809K | Sell |
7,608
-162
| -2% | -$17.5K | 0.09% | 121 |
|
|
2022
Q4 | $862K | Buy |
7,770
+402
| +5% | +$41.1K | 0.09% | 116 |
|
|
2022
Q3 | $635K | Sell |
7,368
-561
| -7% | -$50.1K | 0.07% | 139 |
|
|
2022
Q2 | $723K | Buy |
7,929
+871
| +12% | +$77.2K | 0.1% | 133 |
|
|
2022
Q1 | $579K | Buy |
7,058
+674
| +11% | +$53.1K | 0.06% | 149 |
|
|
2021
Q4 | $489K | Sell |
6,384
-248
| -4% | -$19.8K | 0.04% | 167 |
|
|
2021
Q3 | $498K | Buy |
6,632
+2,077
| +46% | +$158K | 0.04% | 156 |
|
|
2021
Q2 | $354K | Sell |
4,555
-284
| -6% | -$21.1K | 0.03% | 172 |
|
|
2021
Q1 | $356K | Buy |
4,839
+231
| +5% | +$17K | 0.03% | 156 |
|
|
2020
Q4 | $360K | Buy |
4,608
+748
| +19% | +$57.2K | 0.03% | 143 |
|
|
2020
Q3 | $306K | Sell |
3,860
-909
| -19% | -$71.2K | 0.05% | 145 |
|
|
2020
Q2 | $352K | Buy |
4,769
+268
| +6% | +$20.2K | 0.07% | 133 |
|
|
2020
Q1 | $330K | Sell |
4,501
-640
| -12% | -$50.3K | 0.07% | 126 |
|
|
2019
Q4 | $446K | Sell |
5,141
-139
| -3% | -$11.4K | 0.09% | 128 |
|
|
2019
Q3 | $424K | Sell |
5,280
-27
| -0.5% | -$2.16K | 0.08% | 129 |
|
|
2019
Q2 | $425K | Sell |
5,307
-106
| -2% | -$8.12K | 0.07% | 131 |
|
|
2019
Q1 | $430K | Buy |
5,413
+1,556
| +40% | +$116K | 0.08% | 125 |
|
|
2018
Q4 | $281K | Buy |
3,857
+60
| +2% | +$4.24K | 0.06% | 149 |
|
|
2018
Q3 | $257K | Sell |
3,797
-1,169
| -24% | -$74.5K | 0.04% | 154 |
|
|
2018
Q2 | $288K | Buy |
+4,966
| New | +$280K | 0.05% | 147 |
|
|
2018
Q1 | – | Sell |
-3,738
| Closed | -$201K | – | 186 |
|
|
2017
Q4 | $201K | Buy |
3,738
+96
| +3% | +$5.32K | 0.03% | 175 |
|
|
2017
Q3 | $222K | Buy |
+3,642
| New | +$221K | 0.04% | 159 |
|
|
2017
Q2 | – | Sell |
-4,784
| Closed | -$290K | – | 190 |
|
|
2017
Q1 | $290K | Buy |
+4,784
| New | +$290K | 0.04% | 136 |
|
|
2016
Q4 | – | Sell |
-3,665
| Closed | -$218K | – | 208 |
|
|
2016
Q3 | $218K | Hold |
3,665
| – | – | 0.04% | 181 |
|
|
2016
Q2 | $201K | Sell |
3,665
-360
| -9% | -$19.2K | 0.05% | 180 |
|
|
2016
Q1 | $203K | Buy |
+4,025
| New | +$197K | 0.05% | 174 |
|
|
2014
Q2 | – | Sell |
-3,962
| Closed | -$215K | – | 163 |
|
|
2014
Q1 | $215K | Sell |
3,962
-315
| -7% | -$16.3K | 0.01% | 148 |
|
|
2013
Q4 | $204K | Sell |
4,277
-141
| -3% | -$6.45K | 0.02% | 159 |
|
|
2013
Q3 | $201K | Buy |
+4,418
| New | +$202K | 0.01% | 152 |
|
Other funds holding MRK
VCM
VPM
Greenwich Wealth Management's MRK Position: Q1 2026 in Review
Greenwich Wealth Management reduced its Merck (MRK) stake by 1.7% in Q1 2026, selling an estimated $15.8K and leaving 7,921 shares worth $953K. The position accounts for 0.04% of the portfolio, ranked #156.
Greenwich Wealth Management first reported a position in MRK in Q3 2013 and has held it in 41 quarters since. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Greenwich Wealth Management held 7,921 shares of Merck worth $953K as of Q1 2026.
- Greenwich Wealth Management sold 137 Merck shares in Q1 2026, an estimated $15.8K.
- Merck made up 0.04% of Greenwich Wealth Management's portfolio in Q1 2026, its #156 holding.
- Greenwich Wealth Management first reported a position in Merck in Q3 2013 and has held it in 41 quarters since.
- 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Greenwich Wealth Management's 13F filing for Q1 2026, filed 12 May 2026.